Compare IMA & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMA | VERI |
|---|---|---|
| Founded | 2019 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.3M | 57.7M |
| IPO Year | 2021 | 2017 |
| Metric | IMA | VERI |
|---|---|---|
| Price | $4.11 | $0.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $18.00 | $4.50 |
| AVG Volume (30 Days) | 12.1K | ★ 3.8M |
| Earning Date | 11-20-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $800,000.00 | ★ $92,637,000.00 |
| Revenue This Year | N/A | $11.05 |
| Revenue Next Year | N/A | $33.37 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.88 | $0.51 |
| 52 Week High | $8.84 | $6.13 |
| Indicator | IMA | VERI |
|---|---|---|
| Relative Strength Index (RSI) | 42.78 | 33.63 |
| Support Level | $3.91 | N/A |
| Resistance Level | $6.13 | $0.67 |
| Average True Range (ATR) | 0.22 | 0.06 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 39.48 | 18.09 |
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has presence in the United States, the United Kingdom, France, Australia, Israel, and India.